Group items tagged

Since its inception in 1958, the Hearing Health Foundation has supported hearing and balance research elucidating the etiology, diagnosis and treatment, genetics, normal and abnormal function, mechanisms, and development of animal models. As the largest nonprofit funder of hearing and balance research, HHF awards emerging researchers grants to stimulate research that leads to a continuing, independently fundable line of research. As part of this mission, the foundation is seeking applications for new avenues in a number of areas of hearing and balance science, including central auditory processing disorders, hearing loss in children, hyperacusis, Meniere's disease, stria, tinnitus, and Usher syndrome. HHF also encourages applications in the areas of general hearing health, including the physiology of hearing and balance; the epidemiology of auditory and vestibular disorders; human otopathology; the diagnosis, treatment, and prevention of hearing loss and balance disturbance; human genetics and mouse models of peripheral and central auditory/balance dysfunction; innovation in cellular and molecular therapies; and auditory and vestibular implants and hearing aids.

The mission of the Hearing Health Foundation is to prevent and cure hearing loss and tinnitus through groundbreaking research and promote hearing health. HHF envisions a world where people can enjoy life without hearing loss and tinnitus. To advance this mission, the foundation has issued a Call for Applications for its 2018 Emerging Research Grants program for projects designed to explore new avenues in specified topic areas of hearing and balance science. For the 2018 ERG cycle, grants of up to $30,000 will be awarded for research in seven priority areas, including general hearing health, central auditory processing disorders, hearing loss in children, hyperacusis, Ménière's disease, tinnitus, and Usher's syndrome.

This funding opportunity announcement (FOA) encourages Exploratory/Developmental Phased Innovation (R21/R33) grant applications to support research and/or infrastructure needs in emerging scientific areas leading to more accessible and affordable hearing health care for adults with mild to moderate hearing loss. The proposed research aims should be milestone-driven and lead to better hearing healthcare, targeting enhanced access and affordability, in an effort to improve outcomes for adults with hearing loss. The total project period for an application submitted in response to this FOA may not exceed five years. This FOA provides support for up to two years (R21 phase) for preliminary/developmental studies, followed by possible transition of up to four years of expanded research and development support (R33), although the total duration of the award may not exceed five years. This FOA requires measurable R21 milestones.

The Centers for Disease Control and Prevention (CDC), Early Hearing Detection and Intervention (EHDI) program supports the success of all children who are deaf or hard of hearing (D/HH) in the United States by helping to ensure they receive a newborn screening, early diagnosis, and timely intervention services. Without timely screening, diagnosis and intervention, children who are D/HH lose valuable time in gaining the skills that will put them on a trajectory to have language on par with their hearing peers in kindergarten and be ready to succeed in school. Additionally, among children who are D/HH, delays in language development are more difficult to remediate with late diagnosis and intervention. While collaborative efforts by CDC, states, and other partners have helped lead to the early identification of thousands of children who are D/HH each year, their developmental and language outcomes are often unknown, and these data are not routinely collected by CDC or state EHDI programs. Furthermore, it is currently unclear what actions beyond early identification should be taken by public health to help reduce adverse consequences of hearing loss and ensure that children who are D/HH are ready for success in early childhood. The current lack of public health capacity to document and assess the intervention services and associated outcomes of early-identified children who are D/HH at the state and national level makes it challenging to: Assess the developmental progress to ensure all children who are D/HH are achieving age-appropriate milestones and are ready for success in early childhood; Identify strategies, in addition to those beyond early identification, to help assess and reduce adverse consequences of hearing loss; Assess and document the success and impact of EHDI activities across the United States.

Through the program, one-year grants of up to $40,000 will be awarded to projects that investigate various aspects of hearing and balance disorders related to the inner ear. Priority will be given to investigators early in their careers who need seed funds to generate results and data that can be used to support applications for larger grants (i.e., NIH grants) in the future. Projects should relate to the hearing or balance functions of the ear. Both basic and clinical studies that investigate aspects of the auditory and vestibular systems, including but not limited to genetics, neurotology, anatomy, auditory processing, molecular and cellular biology, therapeutic studies, and investigations of current or experimental devices (i.e., cochlear implants), may be proposed. Funding may only be used for direct costs, including salaries of technical and supporting staff, equipment related to the research, and supplies. The grants will not support the salary of the principal investigator, travel or conference attendance, or educational costs.

Through the Emerging Research Grant (ERG) program, Hearing Health Foundation annually awards grants to up and coming scientists who research under-funded and under-researched hearing disorders, including tinnitus, hyperacusis, Central Auditory Processing Disorder, and Ménière's Disease, among others.

Through the Emerging Research Grant (ERG) program, Hearing Health Foundation annually awards grants to up and coming scientists who research under-funded and under-researched hearing disorders, including tinnitus, hyperacusis, Central Auditory Processing Disorder, and Ménière's Disease, among others.

For the 2018 ERG cycle, grants of up to $30,000 will be awarded for research in seven priority areas, including general hearing health, central auditory processing disorders, hearing loss in children, hyperacusis, Ménière's disease, tinnitus, and Usher's syndrome.

This FOA encourages applications for research on hearing health care in adults in support of improving access and affordability.  Further research is needed to strengthen the evidence base with a goal of delivering better hearing health care outcomes in adults.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage basic or clinical research applications that investigate central neural mechanisms of age-related hearing loss in older adults and/or in relevant animal models. This FOA is driven by the need to address a major gap in our understanding of the central pathways and neural networks that are involved in hearing loss and how these may be altered in the context of the aging brain, as well as how natural aging influences central auditory plasticity.

One-year grants of up to $40,000 will be awarded for projects that investigate various aspects of hearing and balance disorders related to the inner ear. Priority will be given to investigators early in their careers who need seed funds to generate results and data that can be used to support applications for larger grants (i.e., NIH grants) in the future.

The National Institute on Deafness and Other Communication Disorders (NIDCD) invites applications to renew an ongoing NIDCD-supported cooperative agreement, the Conservation of Hearing Study (CHEARS).This study will allow continued assessment of preventable risk factors for hearing loss in two large, ongoing, longitudinal cohort studies, the Nurses' Health Studies I and II. 

his FOA encourages Research Project Grant (R21) applications from institutions/organizations to support research leading to accessible and affordable hearing health care (HHC). The overarching emphasis is on the acquisition of knowledge that can be rapidly translated into new or enhanced approaches for access, assessment or interventions with a goal to delivering better hearing health care outcomes. Applications should seek quality approaches that are effective, affordable and deliverable to those who need them as well as implementable and sustainable in settings beyond the research environment.

This FOA encourages Research Project Grant (R01) applications from institutions/organizations to support research leading to accessible and affordable hearing health care (HHC). The overarching emphasis is on the acquisition of knowledge that can be rapidly translated into new or enhanced approaches for access, assessment or interventions with a goal to delivering better hearing health care outcomes. Applications should seek quality approaches that are effective, affordable and deliverable to those who need them as well as implementable and sustainable in settings beyond the research environment.

This announcement solicits applications for a National Technical Resource Center for Newborn Hearing Screening and Intervention (Center) in support of the Universal Newborn Hearing Screening Program (UNHS).  The purpose of the UNHS program is to utilize specifically targeted and measurable interventions to increase the number of infants who are followed up for rescreening, referral, and intervention after having not passed a physiologic newborn screening examination prior to discharge from the newborn nursery.

What do you get when you mix the view and excitement of Baltimore's Inner Harbor with about 700 grant administrators and researchers from around the world, then add more than 40 NIH and HHS experts in in one location who are eager to share their experiences and knowledge of the NIH grants process? You get the 2014 NIH Regional Seminar on Program Funding and Grants Administration, of course! Once again, "Charm City" will be the location for this once-a-year event June 25-27 at the Renaissance Baltimore Harborplace Hotel. Don't miss this exciting opportunity for investigators, administrators, grant writers and others who are new to the NIH grants process and/or those wanting to hear the latest NIH grants policy and process information first-hand. Learn how to successfully submit an application, navigate on-line resources, gain a better understanding of the peer review process, and hear about the expectations for managing your award.

Hearing Health Foundation (HHF) is requesting research proposals that will significantly advance our understanding of disease mechanisms, or diagnosis and treatment of Ménière's Disease, the inner ear and balance disorder. Areas of interest include the mechanisms of endolymphatic hydrops including mechanisms of cochlear fluid regulation; genetics; the creation of animal models; vertigo; vestibular migraines; the imaging of hydrops; and etiology, diagnosis, and treatment.

This FOA encourages exploratory and developmental research applications for research on hearing health care in adults in support of improving access and affordability. Further research is needed to strengthen the evidence base with a goal of delivering better health care outcomes in adults.

The over-arching goal of this NIDCD R25 program is to support educational activities that foster a better understanding of biomedical research and its implications in the areas of auditory and vestibular research. The complexity of auditory and vestibular biology processes provide our hearing and balance function. Interruption of these processes may occur from a variety of factors, including genetic, environmental and pathogenic agents, and often results in the loss of hearing and balance function. While loss or impairment of these functions are most often non-life-threatening, the disruption to quality of life is substantial. Since August of 2007, the National Institute on Deafness and Other Communication Disorders (NIDCD) (http://www.nidcd.nih.gov/) has supported a special topics course in auditory and vestibular biology. The two to three week course, Biology of the Inner Ear, has been held at the Marine Biological Laboratory in Woods Hole, MA, and has brought together outstanding faculty to provide hands-on instruction to participants. It is the continued intent of the NIDCD to foster the advancement of research methodologies and technologies to improve, hasten and implement new treatments for these disorders and impairments. It is based on this template of excellence that the NIDCD invites R25 applications for support of a special topics course in the auditory and vestibular sciences. The purpose of this five-year initiative is to support three courses to be offered each in years 2021, 2023, and 2025. This will allow for a sustained specialized topics course that provides lecture and hands-on research exposure to the auditory and vestibular sciences. The target audience envisioned for this course consists of advanced graduate students, post-doctoral fellows and established early stage research investigators.

The FY17 HRRP FRA is intended to support functional hearing restoration research that develops and validates assessment techniques and treatment methods using patient-centric outcomes to identify potential predictive indicators for successful treatment of individuals living with functional auditory system deficits. The research in this area should result in refined diagnostic tools and improved evaluation of the effectiveness of therapeutic approaches. Applications involving multidisciplinary collaborations among academia, industry, the military Services, the VA, and other Federal Government agencies are highly encouraged. Under this award mechanism, research may support correlative or observational studies that are associated with an ongoing or completed clinical trial.

The FY17 HRRP TRA mechanism is being offered in this first year of the program to support preclinical translational research that will accelerate the movement of promising initiatives relevant to hearing restoration into clinical applications. The ultimate goal of translational research is to move an observation forward into clinical application and accelerate the clinical introduction of healthcare products, technologies, or practice guidelines. Observations that drive a research idea may be derived from a laboratory discovery, population-based studies, or a clinician's first-hand knowledge of patients and anecdotal data. However, Principal Investigators (PIs) should not view translational research as a one-way continuum from bench to bedside. The research plan should involve a reciprocal flow of ideas and information between basic and clinical science.